SCHEMBL3873971

SCHEMBL3873971

NC(=O)[C@@H]1CCCN1Cc1ccc(-c2cnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cn23)s1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.35
FLT3 P36888 3/20 0.35
POLB P06746 1/20 0.35
TGFBR1 P36897 5/20 0.34
TGFBR2 P37173 3/20 0.34
SCN9A Q15858 1/20 0.33
LCK P06239 1/20 0.33
AURKB Q96GD4 1/20 0.33
EIF2AK4 Q9P2K8 1/20 0.33
AKT1 P31749 1/20 0.33
AKT2 P31751 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
PIK3CA P42336 1/20 0.33
ADORA2A P29274 2/20 0.32
ADORA1 P30542 2/20 0.32
SCN3A Q9NY46 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3872041 0.92 MKNK1 (0.36) FLT3POLBTGFBR1LCKAKT1
SCHEMBL3867609 0.89 POLB (0.36) POLBSCN9AEIF2AK4MKNK1MKNK2
SCHEMBL3877554 0.89 MKNK1 (0.39) FLT3POLBTGFBR1MKNK1MKNK2
SCHEMBL3873973 0.89 GRM2 (0.32) GRM2FLT3POLBTGFBR1TGFBR2
SCHEMBL4713756 0.85 FLT3 (0.41) FLT3TGFBR1AKT1AKT2MKNK1
Hydrochloric Acid SCHEMBL3864674 0.84 FLT3 (0.38) GRM2FLT3POLBTGFBR1TGFBR2
SCHEMBL3872044 0.81 MKNK1 (0.32) POLBAKT1AKT2MKNK1MKNK2
SCHEMBL3846603 0.81 FLT3 (0.41) FLT3TGFBR1TGFBR2
SCHEMBL3867613 0.78 POLB (0.32) POLBSCN9AEIF2AK4
SCHEMBL3877558 0.78 MKNK1 (0.34) POLBMKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed